⌘K

Login Start Free

Home/Filings/4/0001213900-21-030431

4//SEC Filing

Albanna Amro A. 4

Accession 0001213900-21-030431

CIK 0001726711other

View on SEC.gov Company Profile

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 12:20 PM ET

Size

10.5 KB

Accession

0001213900-21-030431

Insider Transaction Report

Form 4

Period: 2021-06-01

Aditx Therapeutics, Inc.ADTX

Albanna Amro A.

DirectorCHIEF EXECUTIVE OFFICER

Transactions

Purchase
Common Stock
2021-06-01$2.90/sh+800$2,320→ 751,520 total
Purchase
Common Stock
2021-06-01$2.95/sh+1,000$2,950→ 750,720 total
Purchase
Common Stock
2021-06-01$2.89/sh+100$289→ 751,620 total
Purchase
Common Stock
2021-06-01$2.93/sh+500$1,465→ 748,720 total
Purchase
Common Stock
2021-06-01$2.95/sh+1,000$2,950→ 749,720 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Aditx Therapeutics, Inc.

CIK 0001726711

Entity typeother

Related Parties

1

filerCIK 0001424733

Filing Metadata

Form type: 4
Filed: Jun 1, 8:00 PM ET
Accepted: Jun 2, 12:20 PM ET
Size: 10.5 KB

View on SEC.gov